Skip To Main Content
YING WANG on Muck Rack

YING WANG

As seen in: Amazon Web Services, Environmental Health Perspectives, British Ecological Society (Wiley), Nature, Wiley Online Library, arXiv, PLOS ONE, ScienceDirect, Frontiers, Frontiers in Medicine and

Get in touch with YING

Contact YING, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Global landscape, research hotspots, and evolutionary trends in childhood adversity and chronic disease research: a bibliometric analysis based on three databases

|
By Yixia Zhou, Weili Jiang, YING WANG, Liuyin Jin, Lindan Sheng, Jianjiang Fang
| Frontiers in Public Health Verified
Abstract Background: Adverse childhood experiences (ACEs) are increasingly recognized as important life-course determinants of chronic disease risk. However, the overall knowledge structure, research hotspots, and developmental trends in this field remain insufficiently characterized. This study aimed to systematically map the global research landscape of childhood adversity and chronic diseases through bibliometric analysis.
Open in Who Shared Issue with article?

The association between metabolic dysfunction-associated fatty liver disease and left ventricular mass index in patients with schizophrenia with long-term hospitalization

|
By Jiahuan Li, Yu Ma, YING WANG, Qing Wu
| Frontiers
Abstract Background: Patients with schizophrenia have a high cardiovascular risk, especially long-term hospitalized cases where physical issues are prominent due to prolonged illness, lifestyle restrictions, and antipsychotic use. Metabolic dysfunction-associated fatty liver disease (MAFLD) is an independent cardiovascular risk factor, but its association with cardiac remodeling remains unclear. This study investigates this relationship to support early screening and targeted intervention.
Open in Who Shared Issue with article?

Mesoporous-Shell Monolayer Plasmonic Architecture Enables Quantitative and Decision-Guided SERS

|
By Guangyao Huang, YING WANG, Yue Fang
| Wiley Online Library Verified
1 Introduction Chemotherapy remains a cornerstone of systemic cancer treatment; however, its effectiveness is fundamentally constrained by the lack of quantitative control over drug exposure rather than by drug availability [1, 2]. Many widely used chemotherapeutic agents, including alkylating agents and anthracyclines, exhibit narrow therapeutic windows, where insufficient systemic exposure compromises tumor suppression while excessive exposure leads to severe dose-limiting toxicities [3-5].
Open in Who Shared Issue with article?
See all 505 licensed articles (609 Total)